Baker Brothers Life Sciences Capital (Gp), Llc
Affiliations
- Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2012-03-09
- Large Shareholder at Xoma Corp (XOMA), 2012-03-09
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-02-03
- Large Shareholder at Pharmacyclics Inc (PCYC), 2012-01-26
- Large Shareholder, Director at Incyte Corp (INCY), 2012-01-18
- Large Shareholder, Director at Synageva Biopharma Corp (GEVA), 2012-01-10
- Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2012-01-05
- Large Shareholder at Adolor Corp (ADLR), 2012-01-03
- Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
- Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
- Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2011-07-05
- Large Shareholder at Vaxgen Inc (VXGN.OB), 2010-07-29
- Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| TZYM | $3.01 | 34,544 | $103,821.99 | 3,540,015 | 2012-03-14 | Filing |
| TZYM | $2.99 | 56,294 | $168,268.40 | 3,505,471 | 2012-03-14 | Filing |
| TZYM | $2.96 | 159,015 | $470,382.27 | 3,449,177 | 2012-03-13 | Filing |
| TZYM | $2.55 | 572,737 | $1,460,479.35 | 3,290,162 | 2012-03-12 | Filing |
| TZYM | $2.34 | 327,769 | $766,848.35 | 2,717,425 | 2012-03-12 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AUXL | $17.25 | 40,781 | $703,390.69 | 5,416,304 | 2011-08-02 | Filing |
| AUXL | $18.04 | 394,404 | $7,114,614.32 | 5,457,085 | 2011-08-01 | Filing |
| AUXL | $18.03 | 260,868 | $4,703,319.61 | 5,851,489 | 2011-08-01 | Filing |
| ADLR | $1.18 | 31,666 | $37,460.88 | 6,666,436 | 2010-10-29 | Filing |
| ADLR | $1.19 | 74,670 | $88,737.83 | 6,698,102 | 2010-10-28 | Filing |